¶ Metabiota
.png)
Metabiota, Inc. is an American epidemiological data company based in San Francisco, California. It was founded by Nathan Wolfe, is a wholly-owned subsidiary of Baktus,[1] and is the for-profit sister company of Global Viral.[2]
¶ History
Metabiota was founded by Nathan Wolfe, who incorporated the company in California on February 1, 2008.[2:1][3]
Metabiota received a $23 million contract with the United States Department of Defense for work between February 2014 and November 2016.[4]
In April 2014, Hunter Biden helped secure funding for Metabiota and a "science project" collaboration with Burisma Holdings in Ukraine.[5][6][7]
On December 3, 2014, Metabiota announced that it had been awarded €80 million through the European Commission's Horizon 2020 program to develop a test and treatment against Ebola.[8]
In May 2015, Metabiota raised $30 million from a new funding round "in part to expand its client base among insurance companies and governments."[2:2] The round was led by Rosemont Seneca Technology Partners.[9]
In September 2015, Google Ventures (GV) invested $1 million in Metabiota, and partnered with the company to offer their clients "forecasting and risk-management tools."[10]
In 2017, Metabiota applauded the introduction of “pandemic bond” insurance products by the World Bank.[11]
Metabiota, Inc. was registered as an "extraprovincial company" with the Government of British Columbia on August 28, 2017.[12]
On August 8, 2018, Metabiota announced it had been awarded a sub-contract from Black & Veatch to support the Defense Threat Reduction Agency (DTRA)'s Cooperative Biological Engagement Program (CBEP) in Iraq.[13]
¶ COVID-19
In 2021, Metabiota was highlighted by the World Economic Forum as one of its "Tech Pioneers."[14]
On September 30, 2021, Metabiota was merged with Baktus Acquisition Corporation, a subsidiary of its parent company, Baktus.[15]
On March 27, 2022, Maria Zakharova of the Ministry of Foreign Affairs of the Russian Federation published an alleged timeline of American-Ukrainian bioweapons research which suggested that Metabiota had begun cooperating with Burisma Holdings on an unnamed "science project in Ukraine" in 2014.[6:1][7:1]
On August 19, 2022, Ginkgo Bioworks announced it would purchase "certain epidemiological data infrastructure assets" from Metabiota and its parent company, Baktus. Metabiota's CEO, Nita Madhav, transferred to Ginkgo Bioworks as part of the transaction, and the assets would be applied to Ginkgo's Concentric public health initiative.[16]
¶ Organization
Metabiota is a partner of the United States Agency for International Development (USAID)'s PREDICT program.[17]
¶ Investors
Investors in Metabiota include:[18][19][20]
- Capricorn Investment Group
- DCVC
- Google Ventures[10:1]
- In-Q-Tel[21]
- Industry Ventures
- Martis Capital[22]
- Obvious Ventures
- Pilot Growth Equity
- Rosemont Seneca Technology Partners[9:1][23]
- Science Finance Venture Capital (SciFi VC)
- SharesPost Investment Management
- Skoll Foundation[24]
- Tao Capital Partners
- Undercurrent
- WP Global Partners
¶ Funding and clientele
Metabiota's clients and funding organizations include:
- African Risk Capacity[2:3]
- Black & Veatch[13:1]
- Centers for Disease Control and Prevention (CDC)
- Defense Threat Reduction Agency (DTRA)
- Horizon 2020[8:1]
- Munich Re[2:4]
- Office of Procurement Operations
- United States Department of Defense (DoD)
- United States Department of Health and Human Services (HHS)
- United States Department of Homeland Security (DHS)[25]
- United States Department of the Army
- United States Department of the Navy
¶ Personnel
| Name | Position | Notes |
|---|---|---|
| Nathan Wolfe | Founder | - |
| Nita Madhav | Chief Executive Officer (former); Agent (former)[3:1] | - |
| Edward Rubin | Chief Science Officer[17:1] | - |
| Tamara Kurtzman | Agent[3:2] | - |
¶ External links
Dmytruk, M. (2022, September 27). S-1/A. Securities and Exchange Commission. http://archive.today/2023.07.23-181701/https://www.sec.gov/Archives/edgar/data/1830214/000119312522252186/d395178ds1a.htm ↩︎
Hope, B. (2015, May 20). Virus Hunter Metabiota Finds Niche in Epidemic Research. Wall Street Journal. http://archive.today/2021.12.23-055051/https://www.wsj.com/amp/articles/virus-hunter-metabiota-finds-niche-in-epidemic-research-1432155621 ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
METABIOTA, INC. (2023, July 23). OpenCorporates. http://archive.today/2023.07.23-173440/https://opencorporates.com/companies/us_ca/3085866 ↩︎ ↩︎ ↩︎
Contract Summary - HDTRA114C0104. Bureau of the Fiscal Service. Retrieved March 23, 2022, from http://archive.today/2022.03.23-165739/https://www.usaspending.gov/award/CONT_AWD_HDTRA114C0104_9700_-NONE-_-NONE- ↩︎
Boswell, J. (2022, March 25). Hunter Biden helped secure millions for biotech research Ukraine. Daily Mail. http://archive.today/2023.02.26-072009/https://www.dailymail.co.uk/news/article-10652127/Hunter-Biden-helped-secure-millions-funding-military-biotech-research-program-Ukraine.html ↩︎
Abelson, R. (2022, March 29). Russian Foreign Ministry Releases Alleged “BioBiden” Timeline of US Bioresearch in Ukraine. The Gateway Pundit. http://archive.today/2022.03.29-193514/https://www.thegatewaypundit.com/2022/03/russian-foreign-ministry-releases-alleged-biobiden-timeline-us-bioresearch-ukraine/ ↩︎ ↩︎
BIOBIDEN - Comment by Maria Zakharova, Russian MFA Spokeswoman. (2022, March 27). Yandex 360. http://archive.today/2022.03.29-165136/https://docs.yandex.ru/docs/view?url=ya-disk-public://GlidhdbCd9V3aTmhXbzKlGgKMEnlf3S3TVYzaxjxLA5JKnGMJTQzAq5fhc22SkPZq/J6bpmRyOJonT3VoXnDag%3D%3D:/BIOBIDEN - Comment by Maria Zakharova.docx&name=BIOBIDEN - Comment by Maria Zakharova.docx ↩︎ ↩︎
Metabiota Inc. (2014, December 3). Metabiota Awarded Funding By European Commission To Help in Fight Against Ebola. PR Newswire. http://archive.today/2023.07.23-160357/https://www.prnewswire.com/news-releases/metabiota-awarded-funding-by-european-commission-to-help-in-fight-against-ebola-300003700.html ↩︎ ↩︎
Naimollah, A. (2015, June). M&A Hit Market Update. Marlin & Associates. https://web.archive.org/web/20210701050512/https://www.marlinllc.com/_media/_data/MarlinNewsletter/hit-monthly-newsletter-june-2015.pdf ↩︎ ↩︎
Billings, M. (2015, September 24). The Daily Startup: Google Ventures Backs Metabiota to Forecast Disease Outbreaks. Wall Street Journal. http://archive.today/2023.01.08-215604/https://www.wsj.com/amp/articles/BL-VCDB-17792 ↩︎ ↩︎
Barrett, S. (2017, November 9). Insurance Post Analysis: Pandemic Bonds. Metabiota. http://archive.today/2022.04.05-193129/https://metabiota.com/news/page/9%23!insurance-post-analysis-pandemic-bonds-146 ↩︎
METABIOTA, INC. OrgBook BC. Retrieved July 23, 2023, from https://www.orgbook.gov.bc.ca/entity/A0103497 ↩︎
Metabiota Gains Government Momentum with Black & Veatch Sub-Contracts for Defense Threat Reduction Programs. (2018, August 8). Metabiota. http://archive.today/2022.03.24-183145/https://metabiota.com/news/page/6%23!metabiota-gains-government-momentum-with-black-197 ↩︎ ↩︎
Metabiota - Technology Pioneers 2021. World Economic Forum. Retrieved July 23, 2023, from http://archive.today/2022.03.28-080208/https://widgets.weforum.org/techpioneers-2021/metabiota/ ↩︎
Agreement of Merger Merging Baktus Acquisition Corporation and Metabiota, Inc. (2021, September 30). COVID Truth Initiative; California Secretary of State. https://covidtruthinitiative.ca/organizations/metabiota/agreement-of-merger-between-baktus-acquisition-corporation-and-metabiota.pdf ↩︎
Ginkgo Bioworks Announces Strategic Purchase of Epidemiological Data Infrastructure Assets. (2022, August 19). Ginkgo Bioworks. https://web.archive.org/web/20230723201728/https://investors.ginkgobioworks.com/news/news-details/2022/Ginkgo-Bioworks-Announces-Strategic-Purchase-of-Epidemiological-Data-Infrastructure-Assets/default.aspx ↩︎
Walsh, B. (2017, May 4). The World Is Not Ready for the Next Pandemic. TIME. http://archive.today/2023.02.13-183538/https://time.com/4766624/next-global-security/ ↩︎ ↩︎
Seed Round - Metabiota - 2014-03-20 - Crunchbase Funding Round Profile. Crunchbase. Retrieved July 23, 2023, from https://www.crunchbase.com/funding_round/metabiota-seed--064581d9 ↩︎
Series A - Metabiota - 2015-05-20 - Crunchbase Funding Round Profile. Crunchbase. Retrieved July 23, 2023, from https://www.crunchbase.com/funding_round/metabiota-series-a--e1caa188 ↩︎
Series B - Metabiota - 2018-12-01 - Crunchbase Funding Round Profile. Crunchbase. Retrieved July 23, 2023, from https://www.crunchbase.com/funding_round/metabiota-series-b--2b7d9d23 ↩︎
In-Q-Tel Portfolio Archive. In-Q-Tel. Retrieved May 25, 2024, from https://web.archive.org/web/20240525234440/https://www.iqt.org/portfolio/ ↩︎
Private Equity Round - Metabiota - 2015-01-01 - Crunchbase Funding Round Profile. Crunchbase. Retrieved July 23, 2023, from https://www.crunchbase.com/funding_round/metabiota-private-equity--c2a22d69 ↩︎
Companies. Rosemont Seneca Technology Partners. Retrieved March 15, 2014, from http://archive.today/2014.03.15-054242/http://www.rstp.com/companies/ ↩︎
Chen, H. (2014, March 20). Metabiota raises $2.38M, brings big-data power to fighting diseases. VentureBeat. https://web.archive.org/web/20230723064001/https://venturebeat.com/business/metabiota-raises-2-38m-brings-big-data-power-to-fighting-diseases/ ↩︎
METABIOTA, INC. Bureau of the Fiscal Service. Retrieved July 23, 2023, from https://web.archive.org/web/20230723155004/https://www.usaspending.gov/recipient/e713dd4d-a96e-9e0d-2136-11afe1758355-P/2010 ↩︎